Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Senores PharmaceuticalsNSE:SENORES +1.14%18 Days Inventory is 123.04 as of Mar. 2026, which is 30% above its 10-year median of 94.94. GuruFocus rates NSE:SENORES with a GF Score™ of 18/100. The stock has 7 warning signs investors should review. Among 923 Drug Manufacturers companies, Senores Pharmaceuticals ranks better than 79.2% on this metric.
The historical rank and industry rank for Senores Pharmaceuticals's Days Inventory or its related term are showing as below:
NSE:SENORES'
s Days Inventory Range Over the Past 10 Years
Min: 66.48 Med: 94.94 Max: 135.52
Current: 100.81
During the past 5 years, Senores Pharmaceuticals's highest Days Inventory was 135.52. The lowest was 66.48. And the median was 94.94.
NSE:SENORES's Days Inventory is ranked better than 79.2% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs NSE:SENORES: 100.81
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Senores Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.74.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Senores Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.51.
Senores Pharmaceuticals (NSE:SENORES) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Senores Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Senores Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Senores Pharmaceuticals Days Inventory Related Terms
Senores Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SENORES vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Senores Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senores Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Senores Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Senores Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Senores Pharmaceuticals (NSE:SENORES) has a Days Inventory of 123.04 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Senores Pharmaceuticals and its competitors. This is 30% above median its historical median of 94.94. Over the past decade, Senores Pharmaceuticals' Days Inventory has ranged from 66.48 to 135.52. According to the industry distribution chart, Senores Pharmaceuticals ranks #192 out of 923 companies in the Drug Manufacturers industry, placing it in the top 20.8%.
Is Senores Pharmaceuticals' Days Inventory too high?
Senores Pharmaceuticals' current Days Inventory of 123.04 is 30% above median its 10-year median of 94.94. Over the past 10 years, this metric has ranged from a low of 66.48 to a high of 135.52. The Drug Manufacturers industry median Days Inventory is 164.38. Senores Pharmaceuticals' value of 123.04 is 25.1% below this industry median. Based on the distribution chart, Senores Pharmaceuticals ranks #192 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Senores Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Senores Pharmaceuticals' Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Senores Pharmaceuticals ranks #192 out of 923 companies for Days Inventory. This places Senores Pharmaceuticals in the top 21% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.38. Senores Pharmaceuticals' value of 123.04 is 25.1% below this benchmark. Historically, Senores Pharmaceuticals' own Days Inventory has ranged from 66.48 to 135.52 over the past decade. While the company's 10-year median is 94.94 vs. the industry median of 164.38, Senores Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Senores Pharmaceuticals's current Days Inventory of 123.04 is 25.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Senores Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senores Pharmaceuticals's current Days Inventory is 123.04, which is 30% above median its own 10-year median of 94.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senores Pharmaceuticals stock overvalued right now?
Senores Pharmaceuticals (NSE:SENORES) has a current Days Inventory of 123.04. The current Days Inventory is 123.04, which is 30% above median its 10-year median of 94.94 and 25.1% below the Drug Manufacturers industry median of 164.38. Senores Pharmaceuticals' overall GF Score™ is 18/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Senores Pharmaceuticals (NSE:SENORES), the current Days Inventory is 123.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Senores Pharmaceuticals Ltd is a research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets of the USA, Canada and United Kingdom across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Its strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing the company as a preferred partner to certain customers. Through data analytics, research, market assessment and experienced management, It strategically identifies commercially underpenetrated molecules to launch products in the Regulated and Emerging Markets.
18GF Score
Get the complete analysis for NSE:SENORES
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SENORES has been successfully added to your 
